CN1144595C - Anticancer capsule - Google Patents
Anticancer capsule Download PDFInfo
- Publication number
- CN1144595C CN1144595C CNB011086262A CN01108626A CN1144595C CN 1144595 C CN1144595 C CN 1144595C CN B011086262 A CNB011086262 A CN B011086262A CN 01108626 A CN01108626 A CN 01108626A CN 1144595 C CN1144595 C CN 1144595C
- Authority
- CN
- China
- Prior art keywords
- parts
- cancer
- capsule
- rhizoma
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to an orally taken anticancer capsule which is prepared by mixing the following traditional Chinese medicine components according to parts by weight: 15 to 25 parts of oldenlandia, 10 to 15 parts of fortune plumyew twig and leaf, 10 to 15 parts of common camptotheca fruit, 8 to 15 parts of paris root, 15 to 18 parts of zedoray rhizome, 10 to 15 parts of common prism tuber, 8 to 10 parts of glabrous sarcandra herb, 10 to 20 parts of ginseng, 10 to 15 parts of turtle shell and 10 to 15 parts of ganoderma by a conventional technology. The product of the present invention can directly inhibit, kill and reduce cancer cells, disperse swelling, relieve pain and enhance the immunity of a body, and the toxic and side effect of radiochemotherapy is reduced. The anticancer capsule is suitable for people with various cancers, such as liver cancer, lung cancer, etc.
Description
Affiliated technical field: the invention belongs to the field of Chinese medicines, specifically is a kind of anti-cancer capsule and preparation method thereof.
Background technology; At present, cancer remains a kind of incurable disease, and the whole world has up to ten million people to die from cancer every year approximately, and cancer is harm people healthy formidable enemies, is that medical circle is being made great efforts the difficult medical problem of capturing.The most toxicity of existing Chinese medicine cancer therapy drug is big, negative interaction is big, and the human response is strong, and is not obvious to the cancerous cell inhibitory action, and the negative interaction of Western medicine and change, radiotheraping method etc. is bigger, and it is very painful that people receive treatment, and therapeutic effect is also not obvious.Therefore, thoroughly beat cancer remains need the hold on target of unremitting effort struggle of people.
The objective of the invention is in order to overcome the defective of prior art, for people provide a kind of anti-cancer capsule and preparation method thereof, this anti-cancer capsule product directly suppresses and subtracts cancerous cell, reducing swelling and alleviating pain, enhancing human body immunity ability extremely, alleviate put, chemical therapy toxic side effect.Be applicable to all kinds of cancer patients such as hepatocarcinoma, pulmonary carcinoma.
The objective of the invention is to realize by following technical proposals.
Summary of the invention: anti-cancer capsule of the present invention is that following Chinese medicine component is mixed, and adopts common process to be processed into oral capsule: 15～25 parts of Herba Hedyotidis Diffusaes, 10～15 parts of Folium et Ramulus Cephalotaxis, 10～15 parts of Fructus Camptothecae Acuminatae, 8～15 parts of Rhizoma Paridis, 15～18 parts of Rhizoma Curcumae, 10～15 parts of rhizoma sparganic, 8～10 parts of Herba Sarcandraes, 10～20 parts of Radix Ginsengs, 10～15 parts of Carapax Trionycis, 10～15 parts of Ganodermas.
In the such scheme, can also add 10～15 parts in Radix Glycyrrhizae (weight portion, surplus same).
Preparation method of the present invention: the extraction process in the above-mentioned common process generally is to adopt pharmaceutically active ingredient in decocting in water or the soak with ethanol extraction, in addition, pharmaceutically active ingredient during the present invention can also adopt and extract with soak with ethanol earlier, and then water decoct medicinal herbs slag further extract in the mode of pharmaceutically active ingredient, its better effects if.
Anti-cancer capsule of the present invention is the inventor according to Chinese medical theory and in conjunction with the property of medicine of above-mentioned each Chinese medicine component, gropes to sum up out through long-term practice.The clinical various cancer patients such as treatment hepatocarcinoma, pulmonary carcinoma that are mainly used in of anti-cancer capsule, curative effect is comparatively obvious.Method of treatment is a replenishing QI to invigorate the spleen, eliminating evil and just do not hinder.Hold up down and do not stay heresy.Has giving consideration to both the incidental and fundamental, the effect of simultaneous elimination and reinforcement.
Its anticancer mechanism of the anti-cancer capsule of the above-mentioned prescription of the present invention and function are: 1, anticancer mechanism: directly cut off the nutrition and the breathing of cancerous cell, each phase that stops cancerous cell causes cancerous cell (lump) distortion, withered until death about dividing and duplicating.2, enhancing human body immunity function improves lymphopoiesis and reticuloendothelial system vigor.3, guarantee and improve hemopoietic function of bone marrow, improve the blood cell composition.4, guarantee the regulatory function of endocrine body fluid, promote hypophysis-adrenal cortex function.Its clinical application effect is: 1, external cancer suppressing ratio can reach 100%, and cancer suppressing ratio can reach the cancer suppressing ratio of chemotherapy medicine at present commonly used in the body; To all kinds of cancer patients especially in, the curative effect of patient with advanced cancer is fairly obvious.After medication 1-2 month, patient's primary tumor cancerous protuberance of 80% is obviously dwindled by metering, and spread and shifts lymph lump partly and eliminate substantially, transference cures such as patient's heating, pain, vomiting, self care ability progressively recovers, and can enter convalescence and treat.Can alleviate put, chemotherapy toxic side effect, strengthen put, chemotherapy effect.
Be embodiments of the invention below, the present invention is not limited only to described embodiment.
The specific embodiment:
Embodiment one
Get 15 parts of 12 parts of 8 parts of 10 parts of 15 parts of 8 parts of 12 parts of 15 parts of 18 parts of Herba Hedyotidis Diffusaes, Folium et Ramulus Cephalotaxis, Fructus Camptothecae Acuminatae, Rhizoma Paridis, Rhizoma Curcumae, rhizoma sparganic, Herba Sarcandraes, Radix Ginsengs, Carapax Trionycis, 10 parts of the Ganodermas of cleaning airing, above-mentioned each component is pulverized the mixing back adopt common process to be processed into oral capsule.The clinical various cancer patients such as treatment hepatocarcinoma, pulmonary carcinoma that are mainly used in, after measuring medication 1-2 month, patient's primary tumor cancerous protuberance of 80% is obviously dwindled, the lymph lump that has spread and shifted is partly eliminated substantially, transference cures such as patient's heating, pain, vomiting, self care ability progressively recovers, and can enter the convalescence treatment.
Embodiment two
Get 12 parts of 12 parts of 18 parts of 10 parts of 12 parts of 15 parts of 10 parts of 15 parts of 12 parts of 22 parts of Herba Hedyotidis Diffusaes, Folium et Ramulus Cephalotaxis, Fructus Camptothecae Acuminatae, Rhizoma Paridis, Rhizoma Curcumae, rhizoma sparganic, Herba Sarcandraes, Radix Ginsengs, Carapax Trionycis, Ganodermas, 10 parts in the Radix Glycyrrhizae of cleaning airing, above-mentioned each component is pulverized the mixing back adopt common process to be processed into oral capsule.The clinical various cancer patients such as treatment hepatocarcinoma, pulmonary carcinoma that are mainly used in, after measuring medication 1-2 month, patient's primary tumor cancerous protuberance of 80% is obviously dwindled, the lymph lump that has spread and shifted is partly eliminated substantially, transference cures such as patient's heating, pain, vomiting, self care ability progressively recovers, and can enter the convalescence treatment.
Embodiment three
Get 20 parts of Herba Hedyotidis Diffusaes cleaning airing, 12 parts of Folium et Ramulus Cephalotaxis, 12 parts of Fructus Camptothecae Acuminatae, 10 parts of Rhizoma Paridis, 15 parts of Rhizoma Curcumae, 12 parts of rhizoma sparganic, 10 parts of Herba Sarcandraes, 15 parts of Radix Ginsengs, 12 parts of Carapax Trionycis, 12 parts of Ganodermas, 12 parts in Radix Glycyrrhizae, adopt following processing technique to make oral capsule: above-mentioned component was pulverized mixings → usefulness soak with ethanol more than 1.5 hours, reflux (amount of alcohol added is 8 times of medical material amounts) more than 1 hour → must ethanol extract and medicinal residues → with the further decocting of medicinal residues more than 30 minutes → medicinal residues discard aqueous extract → merging ethanol extract and aqueous extract → concentrated → drying → granulation → quality inspection, sterilization, packing, finished product warehouse-in etc.The clinical various cancer patients such as treatment hepatocarcinoma, pulmonary carcinoma that are mainly used in, after measuring medication 1-2 month, patient's primary tumor cancerous protuberance of 80% is obviously dwindled, the lymph lump that has spread and shifted is partly eliminated substantially, transference cures such as patient's heating, pain, vomiting, self care ability progressively recovers, and can enter the convalescence treatment.
Embodiment four
Get 25 parts of Herba Hedyotidis Diffusaes cleaning airing, 15 parts of Folium et Ramulus Cephalotaxis, 12 parts of Fructus Camptothecae Acuminatae, 15 parts of Rhizoma Paridis, 18 parts of Rhizoma Curcumae, 15 parts of rhizoma sparganic, 10 parts of Herba Sarcandraes, 20 parts of Radix Ginsengs, 15 parts of Carapax Trionycis, 15 parts of Ganodermas, 10 parts in Radix Glycyrrhizae, make oral capsule through following processing technique: above-mentioned component is pulverized mix → with 55%～60% soak with ethanol 2.5 hours, reflux 1.5 hours (amount of alcohol added is 8～10 times of medical material amounts) → ethanol extract and medicinal residues → with 60 minutes → medicinal residues of the further decocting of medicinal residues discard aqueous extract → merging ethanol extract and aqueous extract → concentrated → drying → granulation → quality inspection, sterilization, packing, finished product warehouse-in etc.The clinical various cancer patients such as treatment hepatocarcinoma, pulmonary carcinoma that are mainly used in, after measuring medication 1-2 month, patient's primary tumor cancerous protuberance of 80% is obviously dwindled, the lymph lump that has spread and shifted is partly eliminated substantially, transference cures such as patient's heating, pain, vomiting, self care ability progressively recovers, and can enter the convalescence treatment.
Claims (3)
1, a kind of anti-cancer capsule, it is characterized in that it is that the following weight parts proportion raw material is mixed, and adopts common process to be processed into oral capsule: 15～25 parts of Herba Hedyotidis Diffusaes, 10～15 parts of Folium et Ramulus Cephalotaxis, 10～15 parts of Fructus Camptothecae Acuminatae, 8～15 parts of Rhizoma Paridis, 15～18 parts of Rhizoma Curcumae, 10～15 parts of rhizoma sparganic, 8～10 parts of Herba Sarcandraes, 10～20 parts of Radix Ginsengs, 10～15 parts of Carapax Trionycis, 10～15 parts of Ganodermas.
2, anti-cancer capsule according to claim 1 is characterized in that wherein also can adding 10～15 parts in Radix Glycyrrhizae.
3, the preparation method of anti-cancer capsule according to claim 1 and 2 it is characterized in that described common process is to extract material effective component with soak with ethanol earlier, and then water decoct medicinal herbs slag is further extracted material effective component.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011086262A CN1144595C (en) | 2001-07-13 | 2001-07-13 | Anticancer capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011086262A CN1144595C (en) | 2001-07-13 | 2001-07-13 | Anticancer capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1337251A CN1337251A (en) | 2002-02-27 |
| CN1144595C true CN1144595C (en) | 2004-04-07 |
Family
ID=4657427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011086262A Expired - Fee Related CN1144595C (en) | 2001-07-13 | 2001-07-13 | Anticancer capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1144595C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125681B (en) * | 2011-03-11 | 2012-06-06 | 李宝国 | Anticancer medicinal patch |
| CN102688385B (en) * | 2012-05-30 | 2013-07-10 | 夏孔彪 | Traditional Chinese medicine for curing intermediate and terminal cancer |
| CN103127296B (en) * | 2013-03-18 | 2015-01-07 | 江苏省中医药研究院 | Traditional Chinese medicine composition with lung cancer chemotherapeutic effect-enhancing and toxicity-reducing functions as well as preparation method and application thereof |
| CN108543036A (en) * | 2018-03-15 | 2018-09-18 | 马鲁平 | A kind of antitumor drug and preparation method thereof |
-
2001
- 2001-07-13 CN CNB011086262A patent/CN1144595C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1337251A (en) | 2002-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100528211C (en) | Traditional Chinese medicine for treating tumor | |
| CN104984297A (en) | Application of pharmaceutical composition in preparation of drugs for treating amenorrhea | |
| CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
| CN108653434A (en) | A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome | |
| CN1144595C (en) | Anticancer capsule | |
| CN103705578B (en) | There is blood fat reducing and Chinese medicine preparation suppressing blood glucose rising effect and preparation method thereof | |
| CN105456428A (en) | Traditional Chinese medicine formula for inhibiting regrowth of tumor cells and preparation method thereof | |
| CN102526444A (en) | Traditional Chinese medicine composition for invigorating kidney and strengthening yang and preparation method thereof | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN101804175A (en) | Anti-cancer Chinese medicinal powder and preparation method thereof | |
| CN115252753A (en) | Traditional Chinese medicine composition for treating insomnia and application thereof | |
| CN103127272A (en) | Chinese medicinal preparation for treating breast disease and preparation method thereof | |
| CN101385818B (en) | Pregnant aid preparation for treating sterility due to inadequate luteal function and preparation method thereof | |
| CN104383349A (en) | Drug for postoperative recovery of bladder cancer and preparation method of drug for postoperative recovery of bladder cancer | |
| CN109876127A (en) | A kind of blood-nourishing angelica capsules and preparation method thereof | |
| CN1814153A (en) | Medicine composition for preventing and treating breast cancer and preparing method | |
| CN1163252C (en) | Tianjian capsule and its preparing process | |
| CN1244372C (en) | Chinese medicinal preparation for treating cardiac blood vessel disease and its preparation method | |
| CN118453821B (en) | Chinese herbal compound preparation for treating cancer pain and preparation method thereof | |
| CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
| CN112691168B (en) | Traditional Chinese medicine composition for preventing and treating nuclear radiation injury and preparation method thereof | |
| CN101700323B (en) | Pharmaceutical composition for preventing and treating liver cancer | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN1205950C (en) | Sanweishenxue capsule for treating aplastic anemia and its preparation technology | |
| CN114177243A (en) | Traditional Chinese medicine composition for preventing and adjuvant therapy of liver tumor and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |